Portfolio Companies News
August 16, 2018MIPS INTERIM REPORT JANUARY – JUN...
7:30 am / August 16, 2018 APR – JUN Net sales increased by 52% to SEK 55.6m (36.6). Adjusted for currency exchange rate effects the increase was 53% Operating profit increased to SEK 21.7m (11.0). Adjusted operating profit* also increased to SEK 21.7m (11.5) Operating profit inclu... read more
August 16, 2018Nexstim Plc Half-Yearly Report 1 Ja...
Company announcement, Helsinki, 16 August 2018 at 9:00 am Highlights, January – June 2018 Nexstim delivered its first Navigated Brain Therapy (NBT®) system in the US for the treatment of Major Depressive Disorder (MDD) following Nexstim's successful launch of the SmartFocusTM TMS technology... read more
August 16, 2018BONESUPPORT - CERAMENT® G Approved...
Lund, Sweden, 18:00 CET, 16 August 2018 - BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, announces that its antibiotic-eluting product CERAMENT G has been approved by Health Canada. CERAMENT G is the first and only CE-marked gentamicin-eluting injectab... read more
August 15, 2018Targovax ASA: Invitation to second ...
Oslo, Norway, 15 August 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, will announce its second quarter and first half year 2018 results on Thursday, 23 August 2018. A presentation by Targovax's management to... read more
August 15, 2018Strongbridge Biopharma plc Announce...
DUBLIN, Ireland and TREVOSE, Pa., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it has terminated the public offering of ordinary shares previously announced on August 14, 2018. The termination results from an assessment ... read more
July 24, 2018Q2 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 112 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.